SanBio (SNBIF) Stock Price, News & Analysis

Company Overview

SanBio Co., Ltd. is a Japan-based biotechnology company focused on developing regenerative cell therapies for disorders of the central nervous system. The company’s research is aimed at repairing or restoring neurological function in patients with conditions that have limited treatment options, including chronic traumatic brain injury and stroke.

SanBio’s lead investigational product, SB623, is a cell-based therapy derived from allogeneic bone marrow mesenchymal stem cells. In Japan, the product received conditional and time-limited approval under the name AKUUGO Injection for the treatment of chronic motor dysfunction caused by traumatic brain injury. SanBio has also conducted clinical development programs evaluating SB623 in patients recovering from stroke.

The company was established in the United States and has operated through Japanese and U.S. business and research operations, with a primary focus on advancing regenerative medicine products through clinical development and commercialization. Its activities include research, clinical testing, regulatory work, and the development of manufacturing capabilities for cell-based therapies.

Key Stats

• Today's Range: C$10.11 to C$10.11
• 50-Day Range: C$10.11 to C$10.11
• 52-Week Range: C$4.65 to C$23.00
• Volume: N/A
• Average Volume: 417 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:SNBIF
• CIK: N/A
• Web: www.sanbio.com
• Phone: 81 3 6264 3481
• Fax: N/A
• Employees: 33
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A